FR2287221A1 - Nouveaux sels de biguanides, leur procede de preparation et leur application en tant que medicaments - Google Patents

Nouveaux sels de biguanides, leur procede de preparation et leur application en tant que medicaments

Info

Publication number
FR2287221A1
FR2287221A1 FR7530907A FR7530907A FR2287221A1 FR 2287221 A1 FR2287221 A1 FR 2287221A1 FR 7530907 A FR7530907 A FR 7530907A FR 7530907 A FR7530907 A FR 7530907A FR 2287221 A1 FR2287221 A1 FR 2287221A1
Authority
FR
France
Prior art keywords
application
preparation process
medicinal products
biguanide salts
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7530907A
Other languages
English (en)
French (fr)
Inventor
Ulf Fischer
Eckehard Lorch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2287221A1 publication Critical patent/FR2287221A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
    • C07C279/26—X and Y being nitrogen atoms, i.e. biguanides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7530907A 1974-10-11 1975-10-09 Nouveaux sels de biguanides, leur procede de preparation et leur application en tant que medicaments Withdrawn FR2287221A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1369774A CH602612A5 (OSRAM) 1974-10-11 1974-10-11

Publications (1)

Publication Number Publication Date
FR2287221A1 true FR2287221A1 (fr) 1976-05-07

Family

ID=4394567

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7530907A Withdrawn FR2287221A1 (fr) 1974-10-11 1975-10-09 Nouveaux sels de biguanides, leur procede de preparation et leur application en tant que medicaments

Country Status (26)

Country Link
US (1) US4028402A (OSRAM)
JP (1) JPS51125718A (OSRAM)
AR (1) AR209457A1 (OSRAM)
AT (1) AT343676B (OSRAM)
BE (1) BE834369A (OSRAM)
BR (1) BR7506595A (OSRAM)
CA (1) CA1053258A (OSRAM)
CH (1) CH602612A5 (OSRAM)
CU (1) CU34371A (OSRAM)
DD (1) DD123322A5 (OSRAM)
DE (1) DE2542598A1 (OSRAM)
DK (1) DK140834B (OSRAM)
ES (1) ES441673A1 (OSRAM)
FI (1) FI752626A7 (OSRAM)
FR (1) FR2287221A1 (OSRAM)
GB (1) GB1473256A (OSRAM)
IE (1) IE41807B1 (OSRAM)
IL (1) IL48116A (OSRAM)
LU (1) LU73557A1 (OSRAM)
NL (1) NL7511890A (OSRAM)
NO (1) NO753447L (OSRAM)
PH (1) PH12279A (OSRAM)
PL (1) PL95259B1 (OSRAM)
SE (1) SE7511357L (OSRAM)
SU (1) SU572200A3 (OSRAM)
ZA (1) ZA755861B (OSRAM)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2401898A1 (fr) * 1977-09-05 1979-03-30 Aec Chim Organ Biolog Nouveau sel de l'acide patoique
DE19616486C5 (de) 1996-04-25 2016-06-30 Royalty Pharma Collection Trust Verfahren zur Senkung des Blutglukosespiegels in Säugern
US20020006899A1 (en) * 1998-10-06 2002-01-17 Pospisilik Andrew J. Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
EP1004304A4 (en) 1996-12-24 2002-10-16 Sumitomo Pharma COMPOSITION CONTAINING ASCORBIC ACID
DE19823831A1 (de) * 1998-05-28 1999-12-02 Probiodrug Ges Fuer Arzneim Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
DE19828113A1 (de) 1998-06-24 2000-01-05 Probiodrug Ges Fuer Arzneim Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
DE19828114A1 (de) 1998-06-24 2000-01-27 Probiodrug Ges Fuer Arzneim Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
DE19834591A1 (de) 1998-07-31 2000-02-03 Probiodrug Ges Fuer Arzneim Verfahren zur Steigerung des Blutglukosespiegels in Säugern
US20030176357A1 (en) * 1998-10-06 2003-09-18 Pospisilik Andrew J. Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
DE19926233C1 (de) 1999-06-10 2000-10-19 Probiodrug Ges Fuer Arzneim Verfahren zur Herstellung von Thiazolidin
DE19940130A1 (de) * 1999-08-24 2001-03-01 Probiodrug Ges Fuer Arzneim Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung
CA2386379C (en) * 1999-10-06 2009-12-15 Toshio Miyata Carbonyl stress-decreasing agent
US20080076811A1 (en) * 2000-01-21 2008-03-27 Bork Balkan Combinations comprising depeptidypeptidase-iv inhibitors and antidiabetic agents
HU229042B1 (en) * 2000-03-31 2013-07-29 Prosidion Ltd Method for the improvement of islet signaling in diabetes mellitus and for its prevention
FR2809310B1 (fr) 2000-05-26 2004-02-13 Centre Nat Rech Scient Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant
JP2005097117A (ja) * 2000-06-30 2005-04-14 Chugai Pharmaceut Co Ltd 糖尿病治療剤
JP2004512299A (ja) * 2000-10-27 2004-04-22 プロバイオドラッグ　アーゲー 神経学的および神経心理学的疾患の治療方法
US7132104B1 (en) 2000-10-27 2006-11-07 Probiodrug Ag Modulation of central nervous system (CNS) dipeptidyl peptidase IV (DPIV) -like activity for the treatment of neurological and neuropsychological disorders
US6890905B2 (en) 2001-04-02 2005-05-10 Prosidion Limited Methods for improving islet signaling in diabetes mellitus and for its prevention
DE10150203A1 (de) 2001-10-12 2003-04-17 Probiodrug Ag Peptidylketone als Inhibitoren der DPIV
US7368421B2 (en) 2001-06-27 2008-05-06 Probiodrug Ag Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis
US20030130199A1 (en) * 2001-06-27 2003-07-10 Von Hoersten Stephan Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
US20040214762A1 (en) * 2001-08-16 2004-10-28 Hans-Ulrich Demuth Use of inhibitors of proline endopeptidase to modulate inositol (1,4,5) triphosphate concentration dependent on intracellular signal cascades
US6844316B2 (en) 2001-09-06 2005-01-18 Probiodrug Ag Inhibitors of dipeptidyl peptidase I
DE60217186T2 (de) 2002-02-28 2007-09-27 Prosidion Ltd. Dpiv-inhibitoren auf glutaminbasis
US20030232761A1 (en) * 2002-03-28 2003-12-18 Hinke Simon A. Novel analogues of glucose-dependent insulinotropic polypeptide
US20040033051A1 (en) * 2002-08-16 2004-02-19 Ip Kiril Kun Wan Method and system for producing and displaying visual presentations which inhibit off-screen duplication
US20050176622A1 (en) * 2002-09-18 2005-08-11 Kerstin Kuhn-Wache Secondary binding site of dipeptidyl peptidase IV (DPIV)
US20040058876A1 (en) * 2002-09-18 2004-03-25 Torsten Hoffmann Secondary binding site of dipeptidyl peptidase IV (DP IV)
KR20100038477A (ko) 2003-05-05 2010-04-14 프로비오드룩 아게 글루타미닐 및 글루타메이트 사이클라제의 이펙터의 용도
EP1620091B1 (en) 2003-05-05 2010-03-31 Probiodrug AG Inhibitors of glutaminyl cyclase
NZ546322A (en) * 2003-10-15 2008-11-28 Probiodrug Ag Use of effectors of glutaminyl and glutamate cyclases
US20050171112A1 (en) * 2003-11-03 2005-08-04 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
US20100099721A1 (en) * 2003-11-03 2010-04-22 Probiodrug Ag Novel compounds for the treatment of neurological disorders
KR101099206B1 (ko) 2004-02-05 2011-12-27 프로비오드룩 아게 신규한 글루타미닐 시클라제 저해제
KR100926417B1 (ko) 2007-01-29 2009-11-12 한올제약주식회사 Ｎ,ｎ―디메틸 이미도디카르본이미딕 디아미드의 초산염,그의 제조방법 및 그를 포함하는 약제학적 조성물
US20080188457A1 (en) * 2007-02-02 2008-08-07 Braincells, Inc. Modulation of Neurogenesis with Biguanides and GSK3-beta Agents
EP2203418B1 (en) * 2007-09-21 2017-10-25 HanAll Biopharma Co., Ltd. N,n-dimethyl imidodicarbonimidic diamide dicarboxylate, method for producing the same and pharmaceutical compositions comprising the same
KR101104912B1 (ko) 2008-01-08 2012-01-12 한올바이오파마주식회사 Ｎ,ｎ―디메틸 이미도디카르본이미딕 디아미드의 니코틴산염, 그의 제조방법 및 그를 포함하는 약제학적 조성물
ES2450148T3 (es) 2008-06-26 2014-03-24 Laboratorios Silanes, S.A. De C.V. Una nueva sal de glicinato de metformina para el control de la glucosa en sangre
WO2010146604A2 (en) 2009-06-18 2010-12-23 Exemed Pharmaceuticals Processes for preparing metformin hydrochloride
WO2011049400A2 (ko) * 2009-10-23 2011-04-28 한올바이오파마주식회사 N,n-디메틸 이미도디카르본이미딕 디아미드의 산 부가염을 포함하는 항암용 약제학적 조성물
KR101324283B1 (ko) 2010-04-27 2013-11-01 한올바이오파마주식회사 바이구아나이드 화합물의 신규 염, 그의 제조방법, 그를 포함하는 약제학적 조성물
WO2018060962A2 (en) 2016-09-30 2018-04-05 Laboratorios Silanes S.A. De C.V. Metformin amino acid compounds and methods of using the same
US11185516B2 (en) 2016-09-30 2021-11-30 Laboratorios Silanes S.A. De C.V. Metformin glycinate, pharmaceutical compositions comprising the same, and methods of using the same
CN106986791A (zh) * 2017-05-11 2017-07-28 杜剑平 一种治疗肿瘤的药物化合物及其制备方法和应用
CN107118130A (zh) * 2017-05-11 2017-09-01 杜剑平 一类治疗肿瘤的药物化合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3179562A (en) * 1961-08-23 1965-04-20 Du Pont Treatment of diabetes with alpha, alpha substituted acetic acid derivatives

Also Published As

Publication number Publication date
DK140834C (OSRAM) 1980-04-28
ES441673A1 (es) 1977-04-01
BR7506595A (pt) 1976-08-17
AR209457A1 (es) 1977-04-29
DK140834B (da) 1979-11-26
NL7511890A (nl) 1976-04-13
US4028402A (en) 1977-06-07
SE7511357L (sv) 1976-04-12
AT343676B (de) 1978-06-12
PH12279A (en) 1978-12-12
CH602612A5 (OSRAM) 1978-07-31
AU8497775A (en) 1977-03-24
IL48116A (en) 1979-07-25
LU73557A1 (OSRAM) 1977-05-24
FI752626A7 (OSRAM) 1976-04-12
IE41807L (en) 1976-04-11
NO753447L (OSRAM) 1976-04-13
DK457475A (OSRAM) 1976-04-12
ATA776375A (de) 1977-10-15
BE834369A (fr) 1976-04-12
DD123322A5 (OSRAM) 1976-12-12
JPS51125718A (en) 1976-11-02
DE2542598A1 (de) 1976-04-22
CA1053258A (en) 1979-04-24
PL95259B1 (pl) 1977-10-31
CU34371A (es) 1979-06-01
GB1473256A (en) 1977-05-11
IE41807B1 (en) 1980-03-26
ZA755861B (en) 1976-08-25
IL48116A0 (en) 1975-11-25
SU572200A3 (ru) 1977-09-05

Similar Documents

Publication Publication Date Title
FR2287221A1 (fr) Nouveaux sels de biguanides, leur procede de preparation et leur application en tant que medicaments
BE800679A (fr) Nouvelle 1,4-dihydropyridines leur procede de preparation et medicament les contenant
BE781879A (fr) Nouveaux 1,4-dihydropyridines dissymetriques leur procede de preparation et leur application comme medicaments
BE747627A (fr) (n-benzoyl-azacucloalkyl)-alkylamines, leur procede de preparation et leurs applications comme medicaments antiparkinsoniens
RO68711A (ro) Procedeu de conditionare a unor medicamente oftalmologice
BE829052A (fr) Nouvelles phenylguanidines substituees, leur procede de preparation et medicament les contenant
BE828686A (fr) Nouvel acide penicillanique, son procede de preparation et medicament le contenant
FR2282893A1 (fr) Derives de thienothiazine utiles en tant que medicaments et leur procede de preparation
FR2340330A1 (fr) Acides polyvinylbenzenesulfoniques, leur procede de preparation et leur application en tant que medicaments
FR2285864B1 (fr) Nouveaux derives polyeniques, leur procede de preparation et leur application en tant que medicaments
BE878028A (fr) Nouvelles imidazoquinoxalines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
BE845581A (fr) Nouvelles oxazolidinones-(2), leur procede de preparation et leur application en tant que medicaments
FR2294708A1 (fr) Nouvelles 3-fluoro-2,3-dihydro-1h-1,4-benzodiazepine-2-ones, utiles en tant que medicaments et leur procede de preparation
FR2351993A1 (fr) Composes 9-(3-o-acyl-b-d-arabinofuranosyl)adeniniques, composes 9-(2,3-di-o-acyl-b-d-arabinofuranosyl)-adeniniques, leur procede de preparation, et leur application en tant que medicaments
BE804092A (fr) Nouveaux 1-ethyl-imidazoles, leur procede de preparation et medicaments les contenant
FR2285870A1 (fr) Nouveaux derives de benzofurane, leur procede de preparation et leur application en tant que medicaments
FR2292472A1 (fr) Nouveaux derives d'isoindole utiles en tant que medicaments, et leur procede de preparation
BE780473A (fr) Derives de lumilysergol, leur procede de preparation et leurs applications comme medicaments notamment adrenolytiques
BE808374A (fr) Nouvelles penicillines, leur procede de preparation et medicament
FR2341584A1 (fr) Nouveaux derives de thienothiazine, leur procede de preparation et leur application en tant que medicaments
FR2273530A2 (fr) Nouveaux acides et sels cyanophenylene-dioxamiques, leur procede de preparation et medicament les contenant
FR2295750A1 (fr) Nouvelles benzylpyrimidines utiles en tant que medicaments et leur procede de preparation
FR2351994A1 (fr) Composes 9-(5-o-acyl-b-d-arabinofuranosyl)-adeniniques, procede pour leur preparation et application en tant que medicaments
BE804161A (fr) Procede de preparation de 3,4-dihydropyridones et medicament contenant ces composes
BE831900A (fr) Nouveaux derives de piperidine utiles en tant que medicaments et procede pour leur preparation

Legal Events

Date Code Title Description
ST Notification of lapse